ATE186528T1 - Indol-carbamate als leukotriene antagonisten - Google Patents

Indol-carbamate als leukotriene antagonisten

Info

Publication number
ATE186528T1
ATE186528T1 AT96926519T AT96926519T ATE186528T1 AT E186528 T1 ATE186528 T1 AT E186528T1 AT 96926519 T AT96926519 T AT 96926519T AT 96926519 T AT96926519 T AT 96926519T AT E186528 T1 ATE186528 T1 AT E186528T1
Authority
AT
Austria
Prior art keywords
pct
carbamates
indole
leucotriene
sec
Prior art date
Application number
AT96926519T
Other languages
English (en)
Inventor
Matthew F Brown
Anthony Marfat
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Application granted granted Critical
Publication of ATE186528T1 publication Critical patent/ATE186528T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/18—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT96926519T 1995-10-10 1996-08-26 Indol-carbamate als leukotriene antagonisten ATE186528T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US500395P 1995-10-10 1995-10-10

Publications (1)

Publication Number Publication Date
ATE186528T1 true ATE186528T1 (de) 1999-11-15

Family

ID=21713630

Family Applications (1)

Application Number Title Priority Date Filing Date
AT96926519T ATE186528T1 (de) 1995-10-10 1996-08-26 Indol-carbamate als leukotriene antagonisten

Country Status (10)

Country Link
US (1) US5965745A (de)
EP (1) EP0863873B1 (de)
JP (1) JP3020612B2 (de)
AT (1) ATE186528T1 (de)
CA (1) CA2234239C (de)
DE (1) DE69605128T2 (de)
DK (1) DK0863873T3 (de)
ES (1) ES2138366T3 (de)
GR (1) GR3032272T3 (de)
WO (1) WO1997013751A1 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5982736A (en) 1997-05-15 1999-11-09 Pierson; Gerald A. Trading card optical compact disc and methods of using and forming same
SK12752000A3 (sk) * 1998-02-25 2001-03-12 Genetics Institute, Inc. Inhibítory fosfolipázových enzýmov, farmaceutický prostriedok s ich obsahom a ich použitie
US6500853B1 (en) 1998-02-28 2002-12-31 Genetics Institute, Llc Inhibitors of phospholipase enzymes
NZ560513A (en) 2005-02-25 2010-07-30 Ono Pharmaceutical Co Indole compound and use thereof
CA2705294C (en) * 2007-11-16 2016-05-17 Abbott Laboratories Methods of treating arthritis by the administration of substituted benzenesulfonamides
TWI469965B (zh) 2008-12-22 2015-01-21 Ono Pharmaceutical Co 乙炔基吲哚化合物
MY162757A (en) 2010-06-21 2017-07-14 Ono Pharmaceutical Co New Crystalline Forms of 4,4’-[4-Fluoro-7-({4-[4-(3-Fluoro-2-Methylphenyl) Butoxy] Phenyl}Ethynyl)-2-Methyl-1H-Indole-1, 3-Diyl] Dibutanoic Acid

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2072125T3 (es) * 1991-10-25 1995-07-01 Ciba Geigy Ag Procedimiento para la obtencion de indoles substituidos.
US5280039A (en) * 1992-11-04 1994-01-18 Pfizer Inc. Bicyclic carbamates and methods of treating inflammatory diseases using the same

Also Published As

Publication number Publication date
DE69605128D1 (de) 1999-12-16
US5965745A (en) 1999-10-12
DE69605128T2 (de) 2000-03-02
JPH10512291A (ja) 1998-11-24
CA2234239C (en) 2003-05-20
EP0863873B1 (de) 1999-11-10
JP3020612B2 (ja) 2000-03-15
GR3032272T3 (en) 2000-04-27
DK0863873T3 (da) 2000-05-08
EP0863873A1 (de) 1998-09-16
WO1997013751A1 (en) 1997-04-17
CA2234239A1 (en) 1997-04-17
ES2138366T3 (es) 2000-01-01

Similar Documents

Publication Publication Date Title
ATE187447T1 (de) 3-phenyl-2-isoxazoline derivate als entzündugshemmende mittel
DK0730579T3 (da) Substituerede indoler som inhibitorer af phosphodiesterase-type-IV
ATE154932T1 (de) Isoxazolinverbindungen als entzündungshemmende mittel
NO963675L (no) Prolegemidler av morfolintakykininreseptorantagonister
ATE169001T1 (de) Substituierte spiro-azaringen als tachykinine rezeptor antagonisten
FI970771A0 (fi) Uusia allergisten sairauksien hoidossa käyttökelpoisia substituoituja piperidiinejä
DE59510244D1 (de) Substituierte pyrimidinverbindungen und deren verwendung
EA200500172A1 (ru) Азабициклопроизводные в качестве антагонистов мускариновых рецепторов
ATE186528T1 (de) Indol-carbamate als leukotriene antagonisten
DE69626321D1 (de) Substituierte 4-(1h-benzimidazol-2-yl-amino)piperidine zur behandlung allergischer erkrankungen
ATE296630T1 (de) Substituierte 8-arylchinoline als pde4-hemmer
ATE244712T1 (de) Piperazino-derivative als neurokininantagonisten
MX9804991A (es) 4-(1h-benzimidazol-2-il)(1,4) diazepanes sustituidos novedosos utiles para el tratamiento de enfermedades alergicas.
PT882038E (pt) N-metil-n-(4-(piperidin-1-il)-2-(aril)butil)benzamidas substituidas vantajosas para o tratamento de doencas alergicas
DK0752990T3 (da) Benzisothiazolderivater som inhibitorer af 5-lipoxygenasebiosyntese
ATE168680T1 (de) Bicyclische carbamate als leukotrien-antagonisten

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee